FDA Rejects BrainStorm Cell Therapeutics ALS Treatment, Shares Plunge
BrainStorm Cell Therapeutics' shares plummet after FDA rejects its ALS treatment, NurOwn. Market impact and company response highlighted.
News
Citigroup Raises $5 Billion in Debt Offering
Citigroup Inc. raises $5 billion in debt through a bond offering, marking its first venture into this area in four years. The offering is set to settl...
Charles M. Hall
Treasury Prices Rise as Yields Retreat from 16-Year Highs
Treasury prices increase as yields decrease from 16-year highs. Market outlook, expert insights, and economic updates on the Federal Reserve's interes...
Charles M. Hall
Rising Energy Prices and Treasury Yields Concern Investors
Investors are concerned about the impact of rising energy prices and U.S. Treasury yields on economic growth. Bespoke Investment Group's research reve...
Charles M. Hall
American Billionaire Ken Griffin in Talks for Transatlantic Takeover of U.K. Newspaper
American hedge fund billionaire Ken Griffin is in talks to assist in funding a transatlantic takeover bid for a U.K. newspaper. This could be his firs...
Charles M. Hall
Time to Shop for Deals
Investors should focus on unloved sectors as interest rates may remain high. Beaten-up bonds and defensive stocks present a golden opportunity for inv...
Charles M. Hall
Verbio Vereinigte BioEnergie Shares Struggle After Biodiesel Price Drop
Shares of Verbio Vereinigte BioEnergie decline after biodiesel price drop, affecting earnings. Sales revenue increases but EBITDA falls. Verbio plans...
Charles M. Hall
The Changing Landscape of Interest Rates
The recent shift in interest rate expectations has significant implications for individuals, businesses, and the economy as a whole. Learn how to navi...
Charles M. Hall
Writers and Studios Reach Tentative Deal to End Hollywood Strike
AMC Entertainment stock surges after breakthrough agreement ends Hollywood strike. Writers and studios reach tentative deal, allowing film production...
Charles M. Hall
Instacart Shares Dip as Analyst Maintains Neutral Rating
Instacart's shares dip as analyst Jake Fuller from BTIG maintains a neutral rating due to market challenges and modest growth prospects. The grocery d...
Charles M. Hall
Popular
All Rights Reserved © 2024